X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare WYETH LTD with Sterling Biotech - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH LTD vs STERLING BIOTECH - Comparison Results

WYETH LTD    Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

STERLING BIOTECH 
   Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WYETH LTD STERLING BIOTECH WYETH LTD/
STERLING BIOTECH
 
P/E (TTM) x 27.7 -1.8 - View Chart
P/BV x 5.3 0.1 7,688.6% View Chart
Dividend Yield % 1.3 0.0 -  

Financials

 WYETH LTD   STERLING BIOTECH
EQUITY SHARE DATA
    WYETH LTD
Mar-13
STERLING BIOTECH
Dec-13
WYETH LTD/
STERLING BIOTECH
5-Yr Chart
Click to enlarge
High Rs1,04411 9,946.7%   
Low Rs8183 24,058.8%   
Sales per share (Unadj.) Rs298.626.8 1,113.8%  
Earnings per share (Unadj.) Rs57.2-15.0 -382.7%  
Cash flow per share (Unadj.) Rs58.4-5.5 -1,069.3%  
Dividends per share (Unadj.) Rs17.000-  
Dividend yield (eoy) %1.80-  
Book value per share (Unadj.) Rs249.554.9 454.6%  
Shares outstanding (eoy) m22.72267.87 8.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.10.3 1,203.0%   
Avg P/E ratio x16.3-0.5 -3,501.0%  
P/CF ratio (eoy) x15.9-1.3 -1,253.1%  
Price / Book Value ratio x3.70.1 2,947.6%  
Dividend payout %29.70-   
Avg Mkt Cap Rs m21,1571,862 1,136.4%   
No. of employees `0000.51.4 36.3%   
Total wages/salary Rs m400547 73.2%   
Avg. sales/employee Rs Th13,787.45,303.3 260.0%   
Avg. wages/employee Rs Th813.0403.8 201.3%   
Avg. net profit/employee Rs Th2,643.3-2,959.0 -89.3%   
INCOME DATA
Net Sales Rs m6,7837,181 94.5%  
Other income Rs m35343 827.7%   
Total revenues Rs m7,1367,223 98.8%   
Gross profit Rs m1,617947 170.8%  
Depreciation Rs m272,543 1.0%   
Interest Rs m64,377 0.1%   
Profit before tax Rs m1,938-5,931 -32.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-50-   
Tax Rs m632-1,924 -32.9%   
Profit after tax Rs m1,301-4,007 -32.5%  
Gross profit margin %23.813.2 180.8%  
Effective tax rate %32.632.4 100.6%   
Net profit margin %19.2-55.8 -34.4%  
BALANCE SHEET DATA
Current assets Rs m6,98414,335 48.7%   
Current liabilities Rs m2,05649,809 4.1%   
Net working cap to sales %72.6-494.0 -14.7%  
Current ratio x3.40.3 1,180.4%  
Inventory Days Days99403 24.6%  
Debtors Days Days24171 14.0%  
Net fixed assets Rs m24455,432 0.4%   
Share capital Rs m227268 84.8%   
"Free" reserves Rs m5,44113,935 39.0%   
Net worth Rs m5,66814,701 38.6%   
Long term debt Rs m259,478 0.3%   
Total assets Rs m7,90173,988 10.7%  
Interest coverage x353.3-0.4 -99,539.7%   
Debt to equity ratio x00.6 0.7%  
Sales to assets ratio x0.90.1 884.6%   
Return on assets %16.50.5 3,300.0%  
Return on equity %22.9-27.3 -84.2%  
Return on capital %34.0-6.4 -529.8%  
Exports to sales %0.225.9 0.8%   
Imports to sales %36.30.2 21,391.8%   
Exports (fob) Rs m151,860 0.8%   
Imports (cif) Rs m2,46512 20,208.2%   
Fx inflow Rs m151,860 0.8%   
Fx outflow Rs m2,67725 10,756.1%   
Net fx Rs m-2,6621,835 -145.1%   
CASH FLOW
From Operations Rs m9231,719 53.7%  
From Investments Rs m317-3,148 -10.1%  
From Financial Activity Rs m-4811,426 -33.7%  
Net Cashflow Rs m759-3 -22,326.5%  

Share Holding

Indian Promoters % 0.0 33.9 -  
Foreign collaborators % 51.1 0.0 -  
Indian inst/Mut Fund % 11.3 0.0 -  
FIIs % 7.2 9.9 72.7%  
ADR/GDR % 0.0 16.9 -  
Free float % 30.4 39.3 77.4%  
Shareholders   21,978 21,482 102.3%  
Pledged promoter(s) holding % 0.0 55.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WYETH LTD With:   GSK PHARMA  ASTRAZENECA PHARMA  DISHMAN PHARMA  PIRAMAL ENTERPRISES  NATCO PHARMA  

Compare WYETH LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Strong Note; Bank & Realty Stocks Rally(Closing)

Indian share markets surged further in the afternoon session and finished in the green for the second straight session on heavy buying in realty stocks, metal stocks and bank stocks.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WYETH LTD SHARE PRICE


Dec 9, 2014 (Close)

TRACK WYETH LTD

  • Track your investment in WYETH LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE WYETH LTD WITH

MARKET STATS